Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TPK inhibitors differentially affect IFN-gamma activities

M Aharon1, I Ben Valid, A Dvilansky

  • 1Department of Hematology, Soroka University Hospital of Kupat Holim, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Anticancer Research
|September 1, 1995
PubMed
Summary

Tyrosine protein kinase inhibitors like genistein and quercetin affected interferon-gamma

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clomiphene as a novel modality for the treatment of acute myeloid leukemia: A pilot phase II study.

Leukemia research·2011
Same author

Acquired chromosome instability in the elderly--the effect of diepoxybutane.

Archives of gerontology and geriatrics·2008
Same author

The voltage-dependent anion channel-1 modulates apoptotic cell death.

Cell death and differentiation·2005
Same author

Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa.

Leukemia·2003
Same author

A comparison of predictive outcomes of APACHE II and SAPS II in a surgical intensive care unit.

American journal of medical quality : the official journal of the American College of Medical Quality·2001
Same author

A reassessment of the fat intake of children from meat and meat products and an estimate of haem iron intakes.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2001

Area of Science:

  • Cell Biology
  • Biochemistry
  • Molecular Pharmacology

Background:

  • Interferon-gamma (IFN-γ) is a cytokine with antiproliferative effects.
  • Tyrosine protein kinases (TPKs) are key signaling enzymes involved in cellular processes.
  • The precise role of TPKs in IFN-γ's antiproliferative mechanisms remains incompletely understood.

Purpose of the Study:

  • To investigate the impact of various TPK inhibitors on IFN-γ-induced antiproliferative effects in WISH cells.
  • To elucidate the involvement of TPKs in IFN-γ's modulation of DNA synthesis and thymidine kinase activity.
  • To explore the potential dissociation between IFN-γ's effects on cellular metabolism and proliferation.

Main Methods:

  • WISH cells were treated with IFN-γ and various TPK inhibitors, including genistein, prunetin, N-α-tosyl-L-lysyl-chloromethane, and quercetin.
  • Assays were performed to measure thymidine incorporation into DNA, thymidine kinase activity, and cell number.
  • Inhibitor effects were evaluated at different concentrations and time points (24 hr and 48 hr).

Main Results:

  • IFN-γ (24 hr) inhibited thymidine incorporation and thymidine kinase activity, but not cell number.
  • Genistein and quercetin dose-dependently reversed IFN-γ's inhibition of thymidine incorporation.
  • Genistein fully reversed thymidine kinase inhibition by IFN-γ, while quercetin had a minimal effect.
  • None of the tested inhibitors antagonized the antiproliferative effect (cell number reduction) of IFN-γ after 48 hr.

Conclusions:

  • TPKs likely play a role in mediating IFN-γ's effects on thymidine metabolism and thymidine kinase activity.
  • The differential impact of inhibitors on thymidine metabolism versus cell proliferation suggests a potential dissociation of IFN-γ's actions.
  • These findings highlight the complexity of using TPK inhibitors to fully clarify cytokine signaling pathways.

Related Experiment Videos